Rare diseases
Investigational molecules
Locations
Ul. Mickiewicza 39, 89-600 Chojnice, Poland
Centrum Medyczne LukaMed Joanna Łuka in Chojnice, Poland specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Acute haemorrhagic ulcerative colitis, Arteriosclerosis, and other specialisations. This site conducts important research.
The medical center is at the forefront of gastroenterology, focusing on innovative treatments for complex digestive disorders. The ongoing research aims to enhance the understanding and management of conditions such as idiopathic and diabetic gastroparesis.
Through rigorous clinical trials, the center is dedicated to discovering optimal therapeutic strategies, improving patient outcomes, and advancing the field of digestive health.
Clinical trials currently enrolling participants at this site.
Testing SAR442970 compared to placebo in adults with moderate to severe Crohn's disease
PolandStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
PolandStudy on the Safety and Effectiveness of Lutikizumab and Adalimumab for Adults with Moderate to Severe Ulcerative Colitis
PolandStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
PolandStudy on the Effects of IDP-118 Lotion (Tazarotene and Halobetasol Propionate) for Children with Moderate to Severe Plaque Psoriasis
PolandStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
PolandStudy on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma
PolandStudy on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis
PolandComparison of Risankizumab and Vedolizumab for Treatment of Moderate to Severe Ulcerative Colitis in Adults Who Have Not Received Targeted Therapies
PolandStudy on Guselkumab for Patients with Moderate to Severe Crohn's Disease
PolandStudy on the Safety and Effectiveness of Naronapride for Adults with Moderate Idiopathic or Diabetic Gastroparesis
PolandStudy on Rifamycin SV for Patients with Mild to Moderate Left-Sided Ulcerative Colitis
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
